None listed
Conditions
Interventions
None listed
Sponsors
Kangbuk Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: [Inclusion Criteria] 1) Male and Female aged 20 or over 2) Non-ST elevation MI or STEMI 3) Atorvastatin(40mg) or Rosuvastatin(20mg) used for the reduction of cholesterol 4) High-intensity statin(atorvastatin 40mg, 80mg, rosuvastatin 20mg) never used or statin-naive **Including intensity of below moderate statin. (moderate intensity statins: rosuvastatin 10mg, atorvastatin 20mg, simvastatin/ezetimibe(vytorin) 10/20mg, simvastatin 40mg, pitavastatin 2mg, fluvastatin XL 80mg, pravastatin 40mg)
Exclusion criteria
Exclusion criteria: [Exclusion Criteria] 1) Cardiogenic shock 2) Iodinated contrast media administration within the previous 10 days 3) high-intensity statin being used(rosuvastatin 20mg, atorvastatin 40mg or 80mg) 4) Current hemo-dialysis or peritoneal dialysis 5) Thyroid diseases 6) An allergy to the radiocontrast medium 7) Patients who should ban statin 8) Pregnancy 9) Refusal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference of the incidence of cystatin C-based contrast-induced nephropathy within 48 hours between the two groups | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference of the incidence of cystatin C-based contrast-induced nephropathy within 72 hours between the two groups | — |
Countries
Korea, Republic of
Contacts
Public ContactHyunju Kim
Kangbuk Samsung Medical Center
Outcome results
None listed